Picture of VectivBio Holding AG logo

VECT — VectivBio Holding AG News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid Cap

VectivBio Holding AG expected to post a loss of 56 cents a share - Earnings Preview

* VectivBio Holding AG  VECT.OQ   VECT.O  is expected
to report
results on April 19.
    * The Basel Basel-stadt-based  company is expected to report
revenue of $4.313 million, according to the mean estimate from 3
analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for VectivBio Holding
AG is
for a loss of 56 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for VectivBio
Holding
AG is $22​, above​ its last closing price of $8.60. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021              -0.66                        
 Sep. 30 2021              -0.61                        
 Jun. 30 2021              -0.51                        ​
 Mar. 31 2021              -0.57                        
 ​​                                                     
                                                        ​
 This summary was machine generated April 17 at 11:10 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on VectivBio Holding AG

See all news